Technology-related distractions are not more detrimental to parent-child interactions than non-digital ones, according to a study.

Published Date: 22 May 2024

The amount of time people spend using technology is increasing, and it's important to understand how this affects day-to-day living. Scientists have created the term "technoference," which refers to technology interference in parent-child interactions.

Read Full News

Latest News

Ultragenyx's Gene Therapy Wins First FDA Approval for Rare Metabolic Disorder

Ultragenyx Pharmaceutical said on Wednesday that its gene therapy became the first to ⁠receive the U.S. Food and Drug Administration's approval to treat a rare metabolic...

Aprepitant Eases Cannabinoid Hyperemesis Syndrome in Teens

Hospitalized adolescents had a shorter stay and speedier symptom resolution with this adjunctive therapy.

Taylor Farms Recalls Salsa, Guacamole on Salmonella Outbreak, Intensifying Food-safety Fears

Taylor Farms is recalling prepared foods containing jalapenos from retailers including Walmart and Whole Foods in several states over potential salmonella contamination, the...

Distinguish Support Gaps From Caregiver Neglect, Docs Urged

Too often, clinicians add medications, appointments, and treatments without considering the cumulative burden has become unmanageable.

Hearing Screening For Preemies May Predict Cognition

Infants born extremely premature who do not pass newborn hearing screening assessments show lower scores on language and cognitive assessments at age 2.

Adults Born Very Preterm Show Distinct Functioning Profiles

Adults born very preterm or with very low birth weight show varied functioning profiles in adulthood, with a higher childhood intelligence quotient associated with positive functioning in adulthood.

Todays Updates

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Can a Betting Market Offer Hope to a Cancer Patient?

As we embrace the power of collective knowledge, we must remember that numbers are just numbers

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

News, features, and commentary about cancer-related issues

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

News, features, and commentary about cancer-related issues

Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML

"This specific formulation of daunorubicin and cytarabine is not the right choice," experts said

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time

Improvements primarily driven by reduction in incidence of relapse

Todays Updates

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Can a Betting Market Offer Hope to a Cancer Patient?

As we embrace the power of collective knowledge, we must remember that numbers are just numbers

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

News, features, and commentary about cancer-related issues

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

News, features, and commentary about cancer-related issues

Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML

"This specific formulation of daunorubicin and cytarabine is not the right choice," experts said

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time

Improvements primarily driven by reduction in incidence of relapse

Latest News

Ultragenyx Pharmaceutical said on Wednesday that its gene therapy became the first to ⁠receive the U.S. Food and Drug Administration's approval to treat a rare metabolic...

Hospitalized adolescents had a shorter stay and speedier symptom resolution with this adjunctive therapy.

Taylor Farms is recalling prepared foods containing jalapenos from retailers including Walmart and Whole Foods in several states over potential salmonella contamination, the...

Too often, clinicians add medications, appointments, and treatments without considering the cumulative burden has become unmanageable.

Infants born extremely premature who do not pass newborn hearing screening assessments show lower scores on language and cognitive assessments at age 2.

Adults born very preterm or with very low birth weight show varied functioning profiles in adulthood, with a higher childhood intelligence quotient associated with positive functioning in adulthood.

News All Time

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Protecting Joint Health and Long-Term Outcomes

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Protecting Joint Health and Long-Term Outcomes

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Individualizing Prophylaxis

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Individualizing Prophylaxis

Advancing Pediatric Hemophilia Care in the Non-Factor Era: From Factor Replacement to Rebalancing Therapies

Advancing Pediatric Hemophilia Care in the Non-Factor Era: From Factor Replacement to Rebalancing Therapies

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Newborn Girls Appear Less Likely to Get Vitamin K, Hepatitis B Shots

Relationship stronger for vitamin K; may be tied to circumcision

AAP Disputes Kennedy's Claim That Vaccine Panel Can't Meet Ahead of Flu Season

The federal government can "restore a lawful ACIP" and meet "at any time," AAP president says

RFK Jr. Goes After Journal That Removed Vaccine Study

"The paper's title tells you it shouldn't be published," said vaccine researcher Paul Offit

Outbreak Kills Over 200; ACIP Investigation Launched; Hackers Demand $75M From Novo

Health news and commentary gathered by MedPage Today staff

Over 770,000 Kids No Longer Receiving SNAP Benefits After Trump Changes Food Program

Arizona has seen the nation's largest percentage decline in SNAP participants

Generic Single-Dose Flu Antiviral Gets FDA's Blessing

Studies have shown baloxavir to be a standout among antivirals commonly used for influenza

Utah Marks a Year of Battling Measles, With No Clear End in Sight

Outbreaks will likely affect whether the U.S. can keep its measles-free designation

The Knicks Just Gave Us a Teaching Moment. Let's Not Waste It.

This historic win offers valuable lessons for young people's mental health

Shorter TB Regimen Matched Standard Care in Rifampicin-Resistant Disease

Protocol can be used in children and pregnant women

The Truth About 'Looksmaxxing'

Dr. Mike addresses the online epidemic affecting teen boys

New Charter Unveiled for CDC's Influential Vaccine Committee

Changes to rules governing ACIP could inject more politicization, experts warn

'Tiniest Penis' Fundraiser; Flu Vaccine Maker Investigated; FDA Rejects Gout Drug

Health news and commentary gathered by MedPage Today staff

Recommended News For You

Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases

Cardiorespiratory fitness lowers the risk of colon, lung, and prostate cancer in MEN and lowers mortality from these diseases.

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.

AI-based breast cancer risk technology receives FDA breakthrough device designation

tobacco use, the severity of their symptoms, and their desire to give up smoking among cancer survivors.

For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.

How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma

Recommended Articles For You

Precision Oncology Education for Future Cancer Specialists 

Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing 

Clinical Decision-Making in Oligometastatic Cancer: A Case-Based Perspective 

Intrapancreatic Fat, Pancreatitis, and Cancer: Role of Cancer-Associated Fibroblasts 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer mortality continuing to decline, says report

2.

Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival

3.

Financial hardship common in patients with cancer

4.

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

5.

Advancing Health in Africa

1.

ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer

2.

Understanding the Importance of Knowing Your MCV Normal Range

3.

Uncovering the Causes of Thrombocytosis: A Journey to Improved Health

4.

What You Need to Know About the Early Warning Signs of Colon Cancer 

5.

Unraveling the Mysteries of Burkitt Lymphoma: A New Hope for Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

2.

Expert Perspectives on Hematology

3.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

4.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

5.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot